Raymond James Financial Downgrades Cascadian Therapeutics (NASDAQ:CASC) to Market ...

Retrieved on: 2018-02-18 16:37:30

Tags for this article:

Politics

Cascadian Therapeutics Inc.

Cascadia

Colonialism

Pacific Northwest

Click the tags to see associated articles and topics

Raymond James Financial Downgrades Cascadian Therapeutics (NASDAQ:CASC) to Market .... View article details on hiswai:

Excerpt

<div><b>Renaissance Technologies</b> LLC grew its position in Cascadian Therapeutics by 28.1% during the 4th quarter. <b>Renaissance Technologies</b> LLC now owns 81,688 shares of the biopharmaceutical company's stock worth $302,000 after purchasing an additional 17,900 shares during the period. OxFORD ...</div>

Article found on:

View Original Article